根据分子病理学量身定制子宫内膜癌治疗:目前的状况和对系统和局部治疗的可能影响
Pedro Ribeiro-Santos1,2, Carolina Martins Vieira1,2, Gilson Gabriel Viana Veloso1,3
1Oncoclínicas&Co-Medica Scientia Innovation Research (MEDSIR), São Paulo 04542-390, Brazil.
International journal of molecular sciences
|July 27, 2024
概括
子宫内膜癌 (EC) 越来越多地通过分子亚型 (如POLE超突变和MSI超突变) 来理解. 根据这些亚型量身定制治疗方法至关重要,但具有挑战性.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子病理学分子病理学
背景情况:
- 子宫内膜癌 (EC) 是一种异质性疾病,全球发病率正在上升.
- 癌症基因组图谱 (TCGA) 将EC分为四种分子亚型:POLE超突变,MSI超突变,副本数量高 (TP53突变) 和副本数量低 (NSMP).
- 最近的FIGO分期结合了POLE突变和p53状态,这是由于预后差异.
研究的目的:
- 根据分子亚型,审查当前的数据和未来的指导方针,以根据分子亚型定制子宫内膜癌治疗.
- 讨论实施治疗决策分子测试的挑战.
主要方法:
- 关于子宫内膜癌分子亚型研究的文献综述.
- 对TCGA和FIGO分类数据的分析.
- 对预后和预测生物标志物的评估.
主要成果:
- 子宫内膜癌表现出不同的分子亚型,预后不同.
- 波尔突变和p53状态越来越多地被纳入临床分期.
- 新兴的生物标志物显示出预测治疗反应的潜力.
结论:
- 分子亚型化对于个性化的子宫内膜癌治疗至关重要.
- 将分子数据集成到临床实践中存在重大挑战.
- 需要进一步的研究来克服测试和实施的障碍.
更多相关视频
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
8.1K
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.8K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K